1-3 of 3
Shichao Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4962: Discovery of cancer-specific E3 ligase ligands for targeted protein degradation

Zhaofu Wang, Lynette Zhang, Zhen Chang, Mengxi Zhao, Guobin Li, Fang Qin, Shichao Ma, Yunfeng Li, Zhongguo Zhang, Xinghao Wang, Ying Kong, Shidi Lou, Sheng Chen, Lanzhen Liu, Shuaijie Xu, Hailong Zhang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4962.
https://doi.org/10.1158/1538-7445.AM2023-4962
Published: 04 April 2023
View articletitled, Abstract 4962: Discovery of cancer-specific E3 ligase ligands for targeted protein degradation
Journal Articles

Abstract 6271: Discovery of BR1733 for the treatment of SWI/SNF deficient or highly vascularized solid tumor

Xinghao Wang, Shichao Ma, Min (Bella) Xie, Lele Wang, Yajun Wang, Song Zhang, Sheng Chen, Lynette Zhang, Yongqi Zhou, Mengxi Zhao, Dandan Li, Guobin Li, Xiao Fan, Hailong Zhang
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6271.
https://doi.org/10.1158/1538-7445.AM2023-6271
Published: 04 April 2023
View articletitled, Abstract 6271: Discovery of BR1733 for the treatment of SWI/SNF deficient or highly vascularized solid tumor
Journal Articles

An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response

Hongping Dong, Shaojun Liu, Xuejie Zhang, Sheng Chen, Lijing Kang, Yanni Chen, Shichao Ma, Xianlei Fu, Yanchao Liu, Hailong Zhang, Bin Zou
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (21): 5587–5596.
https://doi.org/10.1158/0008-5472.CAN-19-0428
Published: 01 November 2019
View articletitled, An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response
Open the PDF for An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response in another window
Includes: Supplementary data